IDEXX Laboratories (IDXX) Competitors

IDEXX Laboratories (NASDAQ:IDXX) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, valuation, community ranking, risk, earnings, media sentiment, institutional ownership and dividends.

Does the media favor IDXX or MDT?

In the previous week, Medtronic had 80 more articles in the media than IDEXX Laboratories. MarketBeat recorded 102 mentions for Medtronic and 22 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.29 beat Medtronic's score of 0.97 indicating that IDEXX Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	19 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Medtronic	56 Very Positive mention(s)	7 Positive mention(s)	27 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk & volatility, IDXX or MDT?

IDEXX Laboratories has a beta of 1.37, meaning that its share price is 37% more volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500.

Do institutionals and insiders believe in IDXX or MDT?

87.8% of IDEXX Laboratories shares are owned by institutional investors. Comparatively, 82.1% of Medtronic shares are owned by institutional investors. 2.1% of IDEXX Laboratories shares are owned by company insiders. Comparatively, 0.2% of Medtronic shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Do analysts prefer IDXX or MDT?

IDEXX Laboratories currently has a consensus target price of $533.75, suggesting a potential upside of 17.85%. Medtronic has a consensus target price of $95.00, suggesting a potential upside of 7.78%. Given IDEXX Laboratories' stronger consensus rating and higher possible upside, research analysts clearly believe IDEXX Laboratories is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.80
Medtronic	1 Sell rating(s)	9 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.38

Does the MarketBeat Community prefer IDXX or MDT?

Medtronic received 1052 more outperform votes than IDEXX Laboratories when rated by MarketBeat users. Likewise, 75.48% of users gave Medtronic an outperform vote while only 72.14% of users gave IDEXX Laboratories an outperform vote.

Company	Underperform	Outperform
IDEXX Laboratories	Outperform Votes 536 72.14%	Underperform Votes 207 27.86%
Medtronic	Outperform Votes 1588 75.48%	Underperform Votes 516 24.52%

Which has higher valuation and earnings, IDXX or MDT?

Medtronic has higher revenue and earnings than IDEXX Laboratories. Medtronic is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$3.90B	9.52	$887.87M	$10.67	42.45
Medtronic	$32.36B	3.49	$3.68B	$3.29	26.79

Is IDXX or MDT more profitable?

IDEXX Laboratories has a net margin of 22.78% compared to Medtronic's net margin of 12.83%. IDEXX Laboratories' return on equity of 55.82% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	22.78%	55.82%	26.48%
Medtronic	12.83%	14.11%	7.70%

Summary

IDEXX Laboratories beats Medtronic on 13 of the 18 factors compared between the two stocks.